# Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.

> **NCT01424462** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** A
- **DRUG:** B
- **DRUG:** C
- **DRUG:** D

## Key facts

- **NCT ID:** NCT01424462
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04-19
- **Primary completion:** 2010-07-06
- **Final completion:** 2010-07-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01424462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01424462, "Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01424462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*